Imipenem/Cilastatin and Ganciclovir Interaction

Drug interaction information between Imipenem/Cilastatin and Ganciclovir.

Imipenem/Cilastatin and Ganciclovir have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Imipenem/Cilastatin and Ganciclovir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Imipenem/Cilastatin

Carbapenem Antibiotic Combination

Drug B

Ganciclovir

Antiviral (Nucleoside Analog)

How They Interact

Using these two drugs at the same time can increase the chance of having a seizure.

FDA Label Information

7 DRUG INTERACTIONS Ganciclovir: Generalized seizures have been reported in patients who received ganciclovir. 7.1 Ganciclovir Generalized seizures have been reported in patients who received ganciclovir and PRIMAXIN.

Imipenem/Cilastatin Also Interacts With

View all Imipenem/Cilastatin interactions →

Frequently Asked Questions

What SPL severity band is on file for Imipenem/Cilastatin + Ganciclovir?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Ganciclovir has 9 labeled pairs on file vs Imipenem/Cilastatin's 2. In the minor band specifically: Imipenem/Cilastatin has 1; Ganciclovir has 7 (also Trimethoprim, Probenecid, Bictegravir, Emtricitabine/Tenofovir).

What mechanism field is on file for Imipenem/Cilastatin and Ganciclovir?

Using these two drugs at the same time can increase the chance of having a seizure.

Ganciclovir's labeled portfolio outnumbers Imipenem/Cilastatin

SPL source-record counts only. This page's band is minor · classes on file: Imipenem/Cilastatin (Carbapenem Antibiotic Combination); Ganciclovir (Antiviral (Nucleoside Analog)).

Imipenem/Cilastatin

0 major · 1 moderate · 1 minor · 2 total

Imipenem/Cilastatin has no other minor-band peer in this dataset besides Ganciclovir.

Ganciclovir

0 major · 2 moderate · 7 minor · 9 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.